S Chawla1, L A Loevner1, S G Kim1,2, W-T Hwang3, S Wang1, G Verma1, S Mohan1, V LiVolsi4, H Quon5,6, H Poptani7,8. 1. From the Departments of Radiology (S.C., L.A.L., S.G.K., S.W., G.V., S.M., H.P.). 2. Department of Radiology (S.G.K.), New York University, New York, New York. 3. Biostatistics and Epidemiology (W.-T.H.). 4. Pathology and Lab Medicine (V.L.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Radiation Oncology (H.Q.). 6. Department of Radiation Oncology and Molecular Radiation Sciences (H.Q.), Johns Hopkins University, Baltimore, Maryland. 7. From the Departments of Radiology (S.C., L.A.L., S.G.K., S.W., G.V., S.M., H.P.) Harish.Poptani@liverpool.ac.uk. 8. Department of Cellular and Molecular Physiology (H.P.), University of Liverpool, Liverpool, United Kingdom.
Abstract
BACKGROUND AND PURPOSE: Shutter-speed model analysis of dynamic contrast-enhanced MR imaging allows estimation of mean intracellular water molecule lifetime (a measure of cellular energy metabolism) and volume transfer constant (a measure of hemodynamics). The purpose of this study was to investigate the prognostic utility of pretreatment mean intracellular water molecule lifetime and volume transfer constant in predicting overall survival in patients with squamous cell carcinomas of the head and neck and to stratify p16-positive patients based upon survival outcome. MATERIALS AND METHODS: A cohort of 60 patients underwent dynamic contrast-enhanced MR imaging before treatment. Median, mean intracellular water molecule lifetime and volume transfer constant values from metastatic nodes were computed from each patient. Kaplan-Meier analyses were performed to associate mean intracellular water molecule lifetime and volume transfer constant and their combination with overall survival for the first 2 years, 5 years, and beyond (median duration, >7 years). RESULTS: By the last date of observation, 18 patients had died, and median follow-up for surviving patients (n = 42) was 8.32 years. Patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .01) prolonged overall survival by 5 years compared with those with low mean intracellular water molecule lifetime (13 deaths). Similarly, patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .006) longer overall survival at long-term duration than those with low mean intracellular water molecule lifetime (14 deaths). However, volume transfer constant was a significant predictor for only the 5-year follow-up period. There was some evidence (P < .10) to suggest that mean intracellular water molecule lifetime and volume transfer constant were associated with overall survival for the first 2 years. Patients with high mean intracellular water molecule lifetime and high volume transfer constant were associated with significantly (P < .01) longer overall survival compared with other groups for all follow-up periods. In addition, p16-positive patients with high mean intracellular water molecule lifetime and high volume transfer constant demonstrated a trend toward the longest overall survival. CONCLUSIONS: A combined analysis of mean intracellular water molecule lifetime and volume transfer constant provided the best model to predict overall survival in patients with squamous cell carcinomas of the head and neck.
BACKGROUND AND PURPOSE: Shutter-speed model analysis of dynamic contrast-enhanced MR imaging allows estimation of mean intracellular water molecule lifetime (a measure of cellular energy metabolism) and volume transfer constant (a measure of hemodynamics). The purpose of this study was to investigate the prognostic utility of pretreatment mean intracellular water molecule lifetime and volume transfer constant in predicting overall survival in patients with squamous cell carcinomas of the head and neck and to stratify p16-positive patients based upon survival outcome. MATERIALS AND METHODS: A cohort of 60 patients underwent dynamic contrast-enhanced MR imaging before treatment. Median, mean intracellular water molecule lifetime and volume transfer constant values from metastatic nodes were computed from each patient. Kaplan-Meier analyses were performed to associate mean intracellular water molecule lifetime and volume transfer constant and their combination with overall survival for the first 2 years, 5 years, and beyond (median duration, >7 years). RESULTS: By the last date of observation, 18 patients had died, and median follow-up for surviving patients (n = 42) was 8.32 years. Patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .01) prolonged overall survival by 5 years compared with those with low mean intracellular water molecule lifetime (13 deaths). Similarly, patients with high mean intracellular water molecule lifetime (4 deaths) had significantly (P = .006) longer overall survival at long-term duration than those with low mean intracellular water molecule lifetime (14 deaths). However, volume transfer constant was a significant predictor for only the 5-year follow-up period. There was some evidence (P < .10) to suggest that mean intracellular water molecule lifetime and volume transfer constant were associated with overall survival for the first 2 years. Patients with high mean intracellular water molecule lifetime and high volume transfer constant were associated with significantly (P < .01) longer overall survival compared with other groups for all follow-up periods. In addition, p16-positive patients with high mean intracellular water molecule lifetime and high volume transfer constant demonstrated a trend toward the longest overall survival. CONCLUSIONS: A combined analysis of mean intracellular water molecule lifetime and volume transfer constant provided the best model to predict overall survival in patients with squamous cell carcinomas of the head and neck.
Authors: Martin Lowry; Bashar Zelhof; Gary P Liney; Peter Gibbs; Martin D Pickles; Lindsay W Turnbull Journal: Invest Radiol Date: 2009-09 Impact factor: 6.016
Authors: S Chawla; S Kim; L A Loevner; W-T Hwang; G Weinstein; A Chalian; H Quon; H Poptani Journal: AJNR Am J Neuroradiol Date: 2011-02-24 Impact factor: 3.825
Authors: Xin Li; Ryan A Priest; William J Woodward; Faisal Siddiqui; Tomasz M Beer; Mark G Garzotto; William D Rooney; Charles S Springer Journal: J Magn Reson Date: 2012-03-28 Impact factor: 2.229
Authors: F D Pineda; M Medved; X Fan; M K Ivancevic; H Abe; A Shimauchi; G M Newstead; G S Karczmar Journal: Br J Radiol Date: 2015-03-18 Impact factor: 3.039
Authors: P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff Journal: J Magn Reson Imaging Date: 1999-09 Impact factor: 4.813
Authors: Jin Zhang; Gregory Lemberskiy; Linda Moy; Els Fieremans; Dmitry S Novikov; Sungheon Gene Kim Journal: NMR Biomed Date: 2021-02-25 Impact factor: 4.044
Authors: Wei Huang; Yiyi Chen; Andriy Fedorov; Xia Li; Guido H Jajamovich; Dariya I Malyarenko; Madhava P Aryal; Peter S LaViolette; Matthew J Oborski; Finbarr O'Sullivan; Richard G Abramson; Kourosh Jafari-Khouzani; Aneela Afzal; Alina Tudorica; Brendan Moloney; Sandeep N Gupta; Cecilia Besa; Jayashree Kalpathy-Cramer; James M Mountz; Charles M Laymon; Mark Muzi; Paul E Kinahan; Kathleen Schmainda; Yue Cao; Thomas L Chenevert; Bachir Taouli; Thomas E Yankeelov; Fiona Fennessy; Xin Li Journal: Tomography Date: 2019-03
Authors: Richard Kinh Do; Marsha Reyngold; Ramesh Paudyal; Jung Hun Oh; Amaresha Shridhar Konar; Eve LoCastro; Karyn A Goodman; Amita Shukla-Dave Journal: Tomography Date: 2020-06
Authors: Ramesh Paudyal; Milan Grkovski; Jung Hun Oh; Heiko Schöder; David Aramburu Nunez; Vaios Hatzoglou; Joseph O Deasy; John L Humm; Nancy Y Lee; Amita Shukla-Dave Journal: Cancers (Basel) Date: 2021-08-03 Impact factor: 6.639